Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-Derived Stem Cells for Facial Rejuvenation
NCT02923219Unknown
- Sponsor
- Xuzhou Medical University
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
01
Overview
Open-label, single-arm trial of adipose derived mesenchymal stromal cells in Skin aging, sponsored by Xuzhou Medical University. Primary endpoint: The therapeutic evaluation of adipose-derived stem cells or fat cells solely on facial rejuvenation at 6 months. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT02923219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923219.